Analysts Are Bullish on These Healthcare Stocks: ObsEva SA (OBSV), Albireo Pharma Inc (ALBO)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA (OBSV) and Albireo Pharma Inc (ALBO) with bullish sentiments.

ObsEva SA (OBSV)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ObsEva SA today and set a price target of $44. The company’s shares closed on Friday at $13.90.

Selvaraju commented:

“Valuation methodology, risks and uncertainties. Our risk-adjusted net present value (rNPV) approach ascribes $1.95B to linzagolix (formerly to nolasiban. We utilize an 85% probability of approval for linzagolix and 75% for nolasiban. The current total valuation of $2.3B translates to $44.00 per share, assuming roughly 52M fully-diluted shares outstanding as of end-2019.”

According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 1.0% and a 34.6% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries Ltd., Biospecifics Technologies Corp, and EyePoint Pharmaceuticals Inc.

ObsEva SA has an analyst consensus of Strong Buy, with a price target consensus of $33.40.

See today’s analyst top recommended stocks >>

Albireo Pharma Inc (ALBO)

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Albireo Pharma Inc, with a price target of $62. The company’s shares closed on Friday at $33.10.

According to TipRanks.com, Arce is a 5-star analyst with an average return of 12.3% and a 43.0% success rate. Arce covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, Arcturus Therapeutics Ltd, and Melinta Therapeutics Inc.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Albireo Pharma Inc with a $60.33 average price target, representing an 82.3% upside. In a report issued on April 16, Wedbush also maintained a Buy rating on the stock with a $69 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts